Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens

Congenital Anomalies

Volumn 51, Issue 1, 2011, Pages 16-20

  Chambers, Christina D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cohort study; Human teratogen; Minor defect; Physical examination

Indexed keywords

CARBAMAZEPINE; FLUOXETINE; LEFLUNOMIDE; PHENYTOIN; RETINOIC ACID; TERATOGENIC AGENT; VALPROIC ACID;

BIRTH DEFECT; CASE CONTROL STUDY; CLEFT PALATE; COHORT ANALYSIS; CONGENITAL MALFORMATION; EAR MALFORMATION; EMBRYOPATHY; EPILEPSY; FEVER; HUMAN; HYPOPLASIA; LIMB MALFORMATION; MICROCEPHALY; MICROPHTHALMIA; NEURAL TUBE DEFECT; PHYSICAL EXAMINATION; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RECALL BIAS; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; STUDY DESIGN; TERATOGENESIS; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ARTHRITIS, RHEUMATOID; CARBAMAZEPINE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FEVER; FLUOXETINE; HUMANS; ISOXAZOLES; MATERNAL EXPOSURE; NEURAL TUBE DEFECTS; PHYSICAL EXAMINATION; PREGNANCY; PROSPECTIVE STUDIES; RESEARCH DESIGN; TERATOGENS; TRETINOIN;

EID: 79951780531     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/j.1741-4520.2010.00310.x     Document Type: Review

References (16)

1. Carmichael SL, Ma C, Werler MM, Olney RS, Shaw GM; National Birth Defects Prevention Study (2009) Maternal corticosteroid use and hypospadias. J Ped 155: 39-44.
2. Casper RC, Fleisher BE, Lee-Ancajas JC etal. (2003) Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 142: 402-408.
3. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335: 1010-1015.
4. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1998) Maternal fever and birth outcome: a prospective study. Teratology 58: 251-257.
5. Chambers CD, Braddock SR, Briggs GG etal. (2001) Postmarketing surveillance for human teratogenicity: a model approach. Teratology 64: 252-261.
6. Chambers CD, Johnson DL, Robinson LK etal. (2010) Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum 62: 1494-1503.
7. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. New Engl J Med 343: 1608-1614.
8. Holmes LB, Wyszynski DF, Lieberman E (2004) The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 61: 673-678.
9. Jentink J, Loane MA, Dolk H etal.; EUROCAT Antiepileptic Study Working Group (2010) Valproic acid monotherapy in pregnancy and major congenital malformations. New Engl. J Med 362: 2185-2193.
10. Jones KL, Lacro RV, Johnson KA, Adams J (1989) Pattern of malformations in the children of women treated with carbamazepine during pregnancy. New Engl J Med 320: 1661-1666.
11. Kallen B, Rydhstroem H, Aberg A (1999) Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 93: 392-395.
12. Lammer EJ, Chen DT, Hoar RM etal. (1985) Retinoic acid embryopathy. New Engl J Med 313: 837-841.
13. Leppig KA, Werler MM, Cann CI, Cook CA, Holmes LB (1987) Predictive value of minor anomalies I. Association with major malformations. J Pediatr 110: 531-537.
14. Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA (2007) First trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356: 2675-2683.
15. Loureiro KD, Kao KK, Jones KL etal. (2005) Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet 136A: 117-121.
16. Pleet H, Graham JM Jr, Smith DW (1981) Central nervous system and facial defects associated with maternal hyperthermia at four to 14weeks' gestation. Pediatrics 67: 785-789.